FDA Inspection
Astellas Pharma Inc.Astellas Pharma Inc. – FDA Inspection, Jun 6, 2025
Record Details
This FDA Inspection record concerns Astellas Pharma Inc., with an inspection on June 6, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 94872362-abf5-4e6b-9d98-eeae80d432f2
Inspection Facts
- Inspection number
- 1274304
- FDA center
- Human Drugs
Other FDA inspections of Astellas Pharma Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 13, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 27, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 15, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Astellas Pharma Inc.
- FDA Inspection 1076386 - 2018-12-13
- FDA Inspection 886634 - 2014-06-27
- FDA Inspection 633570 - 2009-10-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.